Dalan Animal Health has raised $13 million across seed-stage funding rounds backed by investors including At One Ventures, VANE (Veterinary Angel Network for Entrepreneurs), Prime Movers Lab, Good Growth Capital, and Meach Cove Capital. These investments support the company’s development of biotechnology solutions that protect pollinators, including the world’s first honeybee vaccine. The funds accelerate commercialization, regulatory expansion, and manufacturing scale. With growing momentum in agricultural biotechnology, Dalan Animal Health is positioned to strengthen pollinator health systems globally and expand its portfolio of preventive solutions for the beekeeping and agriculture industries.